Has Muhammad Hussain, MD received payments from drug or device companies?

Yes. Drug and device makers reported $105,440 in general payments to Muhammad Hussain, MD across 117 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Muhammad Hussain, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Muhammad Hussain, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Muhammad Hussain, MD

Vascular Neurology · Cleveland, OHNPI 1851576193

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $82,421 of the $105,440 with a category attached, or 78.2%. Medical Device Business Services, Inc. accounts for 66.0% of it on its own, with 12 other manufacturers making up the rest. 2025 is the largest year on record at $30,231, 4.8 times the $6,275 reported in 2019. Among vascular neurology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$105,440in general payments, 2019–2025

Across 117 payments — averaging $901.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medical Device Business Services, Inc.$70K
Siemens Medical Solutions USA, Inc.$19K
Stryker$7K
Penumbra, Inc.$6K
Medtronic$1K
Route 92 Medical, Inc.$691
plus $2K from 7 others

$395,053in research payments, 2019–2025

Across 27 payments — averaging $14,632 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

E.r. Squibb & Sons, L.L.C.$218K
Route 92 Medical, Inc.$92K
Medical Device Business Services, Inc.$85K

What the payments were for

Consulting fees$82,42178%
Speaking & faculty fees$3,6003%
Travel & lodging$13,27813%
Food & beverage$6,1416%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medical Device Business Services, Inc.	15	$69,565
Siemens Medical Solutions USA, Inc.	34	$19,192
Stryker	17	$7,218
Penumbra, Inc.	17	$5,689
Medtronic(2 entities)	11	$1,189
Route 92 Medical, Inc.	5	$691
Corindus Inc.	4	$671
Microvention, Inc.	7	$658
Johnson & Johnson	2	$219
Imperative Care, Inc	1	$170
Biosense Webster, Inc.	2	$139
Baxter Healthcare	1	$27
Viz.ai, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

TRUFILL$49,375
EMBOGUARD$8,565
EMBOTRAP II Revascularization Device$7,250
Penumbra System$4,877
SURPASS EVOLVE$4,781
Pulsar Vascular PulseRider Aneurysm Neck Reconstruction Device$4,375
TARGET$1,368
TREVO$1,332
ATLAS$1,200
INFINITY$1,200
TRANSEND$1,200
CorPath GRX$619
Pipeline$591
8F Base Camp Sheath System$545
WEB$393
088 Access System$382
STENT$344
Benchmark$286
Real Immersive System$273
SOLITAIRE X$243

How this compares

$105,440 in reported general payments places this provider in the 95th percentile of 43 vascular neurology providers in Ohio.

See all vascular neurology providers in Ohio →

Medicare billing

Part B allowed, 2024

$34,528

Medicare patients

Services billed

193

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Repatha SureclickEvolocumab	29	$15,229
Atorvastatin Calcium	17	$92

Paid to pharmacies, not to this prescriber.

Other vascular neurology in Cleveland

Gabor TothCleveland$34K
Jenny Peih-Chir TsaiCleveland$27K
Anas AlrohimiCleveland$8K
Mohammad Ammar AbdulrazzakCleveland$3K
Hyeyoung SeolCleveland$1K
Ken UchinoCleveland$397
Marco Gonzalez CastellonCleveland$274
Dolora WiscoCleveland$207
Maria SokolaCleveland$165
Mohammad Jamil AhmadCleveland$161

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →